Stay updated on PF-06801591 Dose Escalation in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T08:44:44.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-11T04:16:05.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.
    Difference
    0.9%
    Check dated 2025-02-24T20:37:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-02-17T14:42:05.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.6%
    Check dated 2025-02-10T09:41:02.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T06:46:48.000Z thumbnail image

Stay in the know with updates to PF-06801591 Dose Escalation in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.